European CHMP recommends license extension of tedizolid (Sivextro)
The license extension is for the treatment of acute bacterial skin and skin structure infections in adolescents 12 years of age and older.
Source:
European Medicines Agency
The license extension is for the treatment of acute bacterial skin and skin structure infections in adolescents 12 years of age and older.
European Medicines Agency